Patents by Inventor Peter Gautschi

Peter Gautschi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Secure transaction processing in a communication system
    Patent number: 10387886
    Abstract: The present invention concerns a method of processing a transaction between a payee and a payor, in a communication system comprising a payor service provider server (32), a payee service provider server (31) and a portable wireless communication device (2) operable by the payor.
    Type: Grant
    Filed: February 11, 2015
    Date of Patent: August 20, 2019
    Inventor: Peter Gautschi
  • SECURE TRANSACTION PROCESSING IN A COMMUNICATION SYSTEM
    Publication number: 20160342998
    Abstract: The present invention concerns a method of processing a transaction between a payee and a payor, in a communication system comprising a payor service provider server (32), a payee service provider server (31) and a portable wireless communication device (2) operable by the payor.
    Type: Application
    Filed: February 11, 2015
    Publication date: November 24, 2016
    Inventor: Peter Gautschi
  • Therapeutic compositions and methods for use of heparin-binding brain mitogens
    Patent number: 5641743
    Abstract: A group of growth factors, designated heparin-binding brain mitogens (HBBMs), is disclosed. The HBBMs are isolated from brain tissue by a sequence of purification steps. The growth factors may be useful in the promotion of angiogenesis, such as in the promotion of wound healing, bone healing and in the treatment of burns, as well as in promoting the formation, maintenance and repair of tissue, in particular, neural tissue.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: June 24, 1997
    Assignee: American Cyanamid Company
    Inventors: Peter Bohlen, Peter Gautschi-Sova
  • Methods for the isolation of heparin-binding brain mitogens
    Patent number: 5270449
    Abstract: A group of growth factors, designated heparin-binding brain mitogens (HBBMs), is disclosed. The HBBMs are isolated from brain tissue by a sequence of purification steps. The growth factors may be useful in the promotion of angiogenesis, such as in the promotion of wound healing, bone healing and in the treatment of burns, as well as in promoting the formation, maintenance and repair of tissue, in particular, neural tissue.
    Type: Grant
    Filed: September 14, 1992
    Date of Patent: December 14, 1993
    Assignee: American Cyanamid Company
    Inventors: Peter Bohlen, Peter Gautschi-Sova
  • Heparin-binding brain mitogens
    Patent number: 5171842
    Abstract: A group of growth factors, designated heparin-binding brain mitogens (HBBMs), is disclosed. The HBBMs are isolated from brain tissue by a sequence of purification steps.
    Type: Grant
    Filed: November 1, 1991
    Date of Patent: December 15, 1992
    Assignee: American Cyanamid Company
    Inventors: Peter Bohlen, Peter Gautschi-Sova